The U.S. Supreme Court recieved an amicus brief on FDA regulation.

Determining the relative costs and benefits of federal regulations often requires putting an implicit price tag on lives, but there is little agreement on the right way to do it. Should all regulations use the same value of a statistical life, or should it vary based on a person's...

This two-volume collection of key papers by leading scholars provides a comprehensive perspective on the evaluation and performance of risk regulation policies.

This monograph assesses how the adverse health implications associated with regulatory costs can affect mortality risk by considering a broad group of federal regulations.